Kaye I. Foster-Cheek is SVP & Global Human Resources at ONYX PHARMACEUTICALS INC (ONXX). They have made 9 open-market trades across 3 companies since 2009, most recently 2026-06-18.
CIK 0001312622
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGIO | SELL | 2024-03-07 | 2024-03-11 | $31.62 | $41K | -1.6% | -2.6% | +53.6% |
| AGIO | SELL | 2024-03-05 | 2024-03-07 | $32.00 | $292K | -5.4% | -12.9% | +53.5% |
| AGIO | SELL | 2023-08-09 | 2023-08-11 | $25.96 | $649K | +2.0% | +1.9% | -19.0% |
| AGIO | SELL | 2018-06-14 | 2018-06-18 | $93.55 | $1.7M | -12.1% | -2.4% | -23.5% |
| AGIO | SELL | 2018-03-19 | 2018-03-21 | $81.97 | $557K | -12.7% | +2.1% | +14.4% |
| ONXX | SELL · 10b5-1 | 2013-08-06 | 2013-08-08 | $132.81 | $1.2M | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-05-07 | 2013-05-08 | $89.84 | $797K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-04-01 | 2013-04-03 | $87.75 | $336K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-02-15 | 2013-02-20 | $74.96 | $1.2M | N/A | N/A | N/A |
| ONXX | SELL | 2012-11-06 | 2012-11-08 | $75.90 | $540K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2012-10-02 | 2012-10-04 | $85.08 | $171K | N/A | N/A | N/A |
| ONXX | SELL | 2012-08-06 | 2012-08-08 | $70.49 | $2.1M | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2012-07-25 | 2012-07-27 | $73.97 | $173K | N/A | N/A | N/A |
| ONXX | SELL | 2011-12-05 | 2011-12-07 | $43.56 | $1.3M | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2011-10-03 | 2011-10-04 | $29.75 | $48K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2011-09-23 | 2011-09-26 | $30.00 | $53K | N/A | N/A | N/A |
| JNJ | SELL | 2009-12-10 | 2009-12-11 | $64.76 | $6.3M | -4.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.